Trial Profile
Prophylactic voriconazole in at-risk patients undergoing liver transplant.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary)
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Adverse reactions; Therapeutic Use
- 04 Nov 2015 New trial record
- 29 Oct 2015 Results published in the Liver Transplantation